venetoclax,obinutuzumab,atezolizumab
abbvie,roche
['obinu', 'lymsm', 'venetoclax', 'dlbcl', 'atezo']
#17icml|anna frustaci,niguarda cancer center, summarize efficacy and safety data from phase ii molto evaluating atezolizumab, venetoclax &amp; obinutuzumab in pts with untreated dlbcl-rs. orr was 67.9% meaning the study met it's primary endpoint; safety profile was favorable
#lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm